Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.
about
PAX3-FOXO1 fusion gene in rhabdomyosarcomaRecent advances in understanding and managing rhabdomyosarcomaPediatric Rhabdomyosarcoma.Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group.A novel algorithm for simplification of complex gene classifiers in cancer.Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcomaGenomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group.The inconvenience of convenience cohorts: rhabdomyosarcoma and the PAX-FOXO1 biomarker.Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupPAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupHigh expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblastsPAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridizationGenetic testing in orbital tumors.Selecting multimodal therapy for rhabdomyosarcoma.Targeted therapy in bone and soft tissue sarcoma in children and adolescents.Myogenic tumors in children and adolescents.What is new in rhabdomyosarcoma management in children?A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Clinical utility gene card for: Alveolar rhabdomyosarcoma.Paratesticular rhabdomyosarcoma in young adult- a case report.Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.Inconvenience of convenience cohorts--letter.Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity.Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach.
P2860
Q24646520-F94987D6-4A2B-4EE0-A2FF-4531B9AB109DQ27024496-A1ECC892-484B-462C-9DBE-91C944BD05DEQ33842070-5B36E841-C0E4-4737-AB92-594E9F691D83Q34508636-D96E1AF4-9978-42DE-83B8-F40889F25D8FQ34520679-74B45DD3-75A8-41BD-AC7F-308EDAF0CF55Q34580128-0C72B3BB-B7CB-4A2B-BFE3-9BFD6006C21FQ34694293-311EB8C1-A900-4DE0-A8D5-107338972FC8Q35689673-9937D785-154A-4E4F-91A2-80736F7A9D5EQ35947244-5919B23D-7E7E-4E12-A179-8FAE3160E118Q36084235-6413ABEE-8FC8-48B6-A4EE-9972A4DFCD00Q36219115-91FD75E8-580B-40C2-9E84-5065843458E9Q36283044-159D3714-16E3-4C60-90B9-96FD48D35402Q37071890-1F1D8E99-E5E9-43D7-A084-87AAC7B9334EQ37462716-31D6FB47-184D-4466-B5A7-78DECAE8CE1DQ37598768-5AC19417-D75C-4A46-9625-8ECC98EC57F0Q37617396-A7E8C4A0-3BBC-40DD-A1BA-2319CF32C994Q37782096-E323D4B6-D829-46E4-97F5-9256A43AFBC3Q37981129-5D8E5E11-43E3-4AFE-9B4B-952D49E50921Q37993928-B34F1FFB-F13F-4227-8B0F-DF0BA2F77E43Q38050831-60194704-C842-4785-96A4-11346B042D89Q38083828-D8632F5D-E4C0-42FB-8B43-F26E6481CAB1Q38238574-B024E69E-F78A-4D60-A63A-65587AF6790FQ38297328-42742E06-52BF-4150-ABFA-351590FB12C9Q38489532-5EBF71DC-C558-4374-8709-01E3139A956AQ38776314-773FE8D9-07EB-4801-9045-BFFE1B72CB88Q39315813-73C7A3E0-0DF5-4ADC-B323-C1A1E7566835Q39701226-84A1DD98-4CE3-4F1F-A8B4-1E126F3BF6D0Q40831030-78E0D522-C69C-4E39-81F7-1E2D2C6C3F2DQ41842448-D1585AF8-DC88-4EB9-A242-8106EEA22832Q42321484-60E86035-F864-440E-B9F2-87C141B00C57Q47850677-FD2CB5E1-FA1C-4020-BF60-432B0A717850Q50195721-EB20DB42-DB0F-40C9-9600-D3E91D74610D
P2860
Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Examination of gene fusion sta ...... the Children's Oncology Group.
@ast
Examination of gene fusion sta ...... the Children's Oncology Group.
@en
type
label
Examination of gene fusion sta ...... the Children's Oncology Group.
@ast
Examination of gene fusion sta ...... the Children's Oncology Group.
@en
prefLabel
Examination of gene fusion sta ...... the Children's Oncology Group.
@ast
Examination of gene fusion sta ...... the Children's Oncology Group.
@en
P2093
P2860
P1476
Examination of gene fusion sta ...... the Children's Oncology Group.
@en
P2093
David M Parham
Donna Strzelecki
Frederic G Barr
James C Lynch
Lynette M Smith
Philip P Breitfeld
Stephen J Qualman
P2860
P304
P356
10.2353/JMOLDX.2006.050124
P577
2006-05-01T00:00:00Z